The iκb kinase complex is required for plexin-B-mediated activation of RhoA

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zielonka, Matthias ^a,b,d   Krishnan, Ramesh K ^a   Swiercz, Jakub M ^a   Offermanns, Stefan ^a,c  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLEXIN; PLEXIN B1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; NERVE PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL; CELL LINE; GENETICS; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; TUMOR CELL LINE;

CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; MCF-7 CELLS; NERVE TISSUE PROTEINS; NF-KAPPA B; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84940290891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105661     Document Type: Article

References (67)

1. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80. (Pubitemid 29468631)
2. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, et al. (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99: 59-69. (Pubitemid 29468630)
3. Furuyama T, Inagaki S, Kosugi A, Noda S, Saitoh S, et al. (1996) Identification of a novel transmembrane semaphorin expressed on lymphocytes. J Biol Chem 271: 33376-33381. (Pubitemid 27010148)
4. Kameyama T, Murakami Y, Suto F, Kawakami A, Takagi S, et al. (1996) Identification of a neuronal cell surface molecule, plexin, in mice. Biochem Biophys Res Commun 226: 524-529. (Pubitemid 26331934)
5. Maestrini E, Tamagnone L, Longati P, Cremona O, Gulisano M, et al. (1996) A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. Proc Natl Acad Sci U S A 93: 674-678. (Pubitemid 26041148)
6. Ishikawa K, Nagase T, Nakajima D, Seki N, Ohira M, et al. (1997) Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro. DNA Res 4: 307-313. (Pubitemid 127698983)
7. Tran TS, Kolodkin AL, Bharadwaj R (2007) Semaphorin regulation of cellular morphology. Annual Review of Cell and Developmental Biology 23: 263-292.
8. Neufeld G, Kessler O (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8: 632-645.
9. Suzuki K, Kumanogoh A, Kikutani H (2008) Semaphorins and their receptors in immune cell interactions. Nat Immunol 9: 17-23. (Pubitemid 350286199)
10. Tamagnone L (2012) Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell 22: 145-152.
11. Oinuma I, Ishikawa Y, Katoh H, Negishi M (2004) The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305: 862-865. (Pubitemid 39038420)
12. Wang Y, He H, Srivastava N, Vikarunnessa S, Chen YB, et al. (2012) Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci Signal 5: ra6.
13. Saito Y, Oinuma I, Fujimoto S, Negishi M (2009) Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. Embo Reports 10: 614-621.
14. Aurandt J, Vikis HG, Gutkind JS, Ahn N, Guan KL (2002) The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci U S A 99: 12085-12090.
15. Perrot V, Vazquez-Prado J, Gutkind JS (2002) Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 277: 43115-43120. (Pubitemid 35285695)
16. Swiercz JM, Kuner R, Behrens J, Offermanns S (2002) Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35: 51-63. (Pubitemid 34804322)
17. Deng S, Hirschberg A, Worzfeld T, Penachioni JY, Korostylev A, et al. (2007) Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo. J Neurosci 27: 6333-6347. (Pubitemid 46890021)
18. Masuda K, Furuyama T, Takahara M, Fujioka S, Kurinami H, et al. (2004) Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. Genes Cells 9: 821-829. (Pubitemid 39199910)
19. Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, et al. (2010) Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Int J Mol Med 26: 39-44.
20. Maier V, Jolicoeur C, Rayburn H, Takegahara N, Kumanogoh A, et al. (2011) Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development. Mol Cell Neurosci 46: 419-431.
21. Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, et al. (2004) Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep 5: 710-714. (Pubitemid 39173007)
22. Swiercz JM, Kuner R, Offermanns S (2004) Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol 165: 869-880. (Pubitemid 38821977)
23. Swiercz JM, Worzfeld T, Offermanns S (2008) ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem 283: 1893-1901.
24. Swiercz JM, Worzfeld T, Offermanns S (2009) Semaphorin 4D signaling requires the recruitment of phospholipase C gamma into the plexin-B1 receptor complex. Mol Cell Biol 29: 6321-6334.
25. Worzfeld T, Swiercz JM, Looso M, Straub BK, Sivaraj KK, et al. (2012) ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. Journal of Clinical Investigation 122: 1296-1305.
26. Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, et al. (2011) Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 17: 1473-1480.
27. Hill CS, Wynne J, Treisman R (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159-1170.
28. Xiang SY, Dusaban SS, Brown JH (2013) Lysophospholipid receptor activation of RhoA and lipid signaling pathways. Biochim Biophys Acta 1831: 213-222.
29. Fukuhara S, Chikumi H, Gutkind JS (2001) RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 20: 1661-1668. (Pubitemid 32336855)
30. Scheidereit C (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705.
31. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, et al. (2003) A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278: 32861-32871. (Pubitemid 37055728)
32. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, et al. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289: 1550-1554.
33. Shih VF, Tsui R, Caldwell A, Hoffmann A (2011) A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 21: 86-102.
34. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663. (Pubitemid 30365393)
35. Kumar A, Eby MT, Sinha S, Jasmin A, Chaudhary PM (2001) The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J Biol Chem 276: 2668-2677.
36. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, et al. (2002) The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 4: 720-724. (Pubitemid 34993710)
37. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, et al. (2002) The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 115: 141-151. (Pubitemid 34105537)
38. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, et al. (2007) Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26: 1385-1397. (Pubitemid 46340818)
39. Jain G, Voogdt C, Tobias A, Spindler KD, Moller P, et al. (2012) IkappaB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines. Neoplasia 14: 178-189.
40. Ochiai T, Saito Y, Saitoh T, Dewan MZ, Shioya A, et al. (2008) Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells. J Med Dent Sci 55: 49-59.
41. Devalaraja MN, Wang DZ, Ballard DW, Richmond A (1999) Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription. Cancer Res 59: 1372-1377. (Pubitemid 29136272)
42. Yang J, Richmond A (2001) Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 61: 4901-4909. (Pubitemid 32691908)
43. Yeh PY, Lu YS, Ou DL, Cheng AL (2011) IkappaB kinases increase Myc protein stability and enhance progression of breast cancer cells. Mol Cancer 10: 53.
44. Hinz M, Scheidereit C (2014) The IkappaB kinase complex in NF-kappaB regulation and beyond. EMBO Rep 15: 46-61.
45. Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12: 695-708.
46. Chariot A (2009) The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 19: 404-413.
47. Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, et al. (2007) IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130: 440-455.
48. Liu F, Xia Y, Parker AS, Verma IM (2012) IKK biology. Immunol Rev 246: 239-253.
49. Lee S, Andrieu C, Saltel F, Destaing O, Auclair J, et al. (2004) IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc Natl Acad Sci U S A 101: 17416-17421. (Pubitemid 39657419)
50. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
51. Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, et al. (2008) IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A 105: 2487-2492. (Pubitemid 351520540)
52. Gareus R, Huth M, Breiden B, Nenci A, Rosch N, et al. (2007) Normal epidermal differentiation but impaired skin-barrier formation upon keratinocytere-stricted IKK1 ablation. Nat Cell Biol 9: 461-469. (Pubitemid 46511080)
53. Liu B, Xia X, Zhu F, Park E, Carbajal S, et al. (2008) IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 14: 212-225.
54. Sil AK, Maeda S, Sano Y, Roop DR, Karin M (2004) IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664. (Pubitemid 38524809)
55. Yang YH, Zhou H, Binmadi NO, Proia P, Basile JR (2011) Plexin-B1 activates NF-kappaB and IL-8 to promote a pro-angiogenic response in endothelial cells. PLoS One 6: e25826.
56. Gupta SC, Prasad S, Reuter S, Kannappan R, Yadav VR, et al. (2010) Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J Biol Chem 285: 35406-35417.
57. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS (2004) Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 64: 5212-5224. (Pubitemid 39006540)
58. Matsumoto T, Abe M (2011) TGF-beta-related mechanisms of bone destruction in multiple myeloma. Bone 48: 129-134.
59. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, et al. (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156-163.
60. Arkan MC, Greten FR (2011) IKK- and NF-kappaB-mediated functions in carcinogenesis. Curr Top Microbiol Immunol 349: 159-169.
61. Bollrath J, Greten FR (2009) IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10: 1314-1319.
62. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237. (Pubitemid 38496242)
63. Liu S, Chen Z, Zhu F, Hu Y (2012) IkappaB kinase alpha and cancer. J Interferon Cytokine Res 32: 152-158.
64. Perkins ND (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121-132.
65. Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, et al. (2011) Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470: 548-553.
66. Ren XD, Schwartz MA (2000) Determination of GTP loading on Rho. Methods Enzymol 325: 264-272.
67. van Triest M, Bos JL (2004) Pull-down assays for guanoside 5′-triphosphate-bound Ras-like guanosine 5′-triphosphatases. Methods Mol Biol 250: 97-102.